Israel Active

I reported on Israel’s Nano Textile previously when it announced its antibacterial Zinc Oxide (ZnO) nano-coating for bed linen and clothing to prevent hospital infections.  Nano Textile has now announced that it can make any fabric (natural or synthetic) antibacterial.

Israel’s NovellusDx monitors the effect of cancer therapies on a patient’s genetic mutations.  NovellusDx reports to the oncologist on the contribution of the driver mutations to the activation of the signaling pathways.  NovellusDx has just received $2.5 million funds from the VC Orbimed.

Israeli Marni Mandell launched the startup CareHood to provide patients and care-givers with a website where they can learn what has helped other people in similar situations. They can then build a care package of services, gifts, tasks and errands that their friends and family can assist with.

Scientists at Bar-Ilan University have used low-level electricity to increase the rate at which daydreams - or spontaneous, self-directed thoughts and associations - occur.  They also discovered that daydreams have a positive effect on task performance.

A new medical innovation, developed at Tel Aviv University’s Center for Nanoscience & Nanotechnology, uses ‘stick it and forget it’ electrodes affixed to the skin, to monitor muscle activity.  Applications include monitoring driver alertness and individuals with neuro-degenerative diseases.

Canada’s federal department responsible for helping Canadians maintain and improve their health, Health Canada, has approved the Exablate Neuro system for the treatment of essential tremor developed by Israel’s Insightec.

The SafeCT-29 solution from Israel’s Medic Vision Imaging Solutions produces high-quality medical scan images but reduces radiation doses by up to 80%.  SafeCT-29 works with any CT scanner and has just been approved by the US FDA.

I reported about Israel’s Check-cap previously () that requires no prior preparation or hospital visit.  After 4 years, trials on 54 participants of its ingestible and disposable low-dose 3D imaging capsule proved safe and well tolerated and detected small and large polyps.

The BBC has just reported that the UK’s National Health Service has approved the funding of patients receiving the pioneering melanoma (skin cancer) treatment developed by Israeli Professor Jacob Schachter. The approval was one of the fastest in NHS history.  The anti-Israel BBC doesn’t mention the Israeli connection, so please read Sheba hospital’s article for details.

I reported previously about Israeli research into bio-ink that could potentially print human organs.  Now two Israeli companies, Nano Dimension and Accelta have successfully lab-tested a proof-of-concept 3D bio-printer.  It may even be able to print stem cells!